Andre Manfred Willasch (MD, PD, PhD)
Andre Manfred Willasch (MD, PD, PhD)
Bestätigte E-Mail-Adresse bei kgu.de
Titel
Zitiert von
Zitiert von
Jahr
Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM …
P Bader, H Kreyenberg, GHR Henze, C Eckert, M Reising, A Willasch, ...
Journal of Clinical Oncology 27 (3), 377-384, 2009
3442009
How and when should we monitor chimerism after allogeneic stem cell transplantation?
P Bader, D Niethammer, A Willasch, H Kreyenberg, T Klingebiel
Bone marrow transplantation 35 (2), 107-119, 2005
2322005
Ketoacidosis at onset of type 1 diabetes mellitus in children–frequency and clinical presentation
A Neu, A Willasch, S Ehehalt, R Hub, MB Ranke, ...
Pediatric diabetes 4 (2), 77-81, 2003
1872003
Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia
IHIM Hollink, MM van den Heuvel-Eibrink, M Zimmermann, BV Balgobind, ...
Blood 113 (23), 5951-5960, 2009
1482009
The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells
E Rettinger, S KuçI, I Naumann, P Becker, H Kreyenberg, M Anzaghe, ...
Cytotherapy 14 (1), 91-103, 2012
1152012
Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending …
P Bader, H Kreyenberg, A von Stackelberg, C Eckert, ...
J Clin Oncol 33 (11), 1275-1284, 2015
1082015
Continuous rise in incidence of childhood Type 1 diabetes in Germany
S Ehehalt, G Blumenstock, AM Willasch, R Hub, MB Ranke, A Neu, ...
Diabetic Medicine 25 (6), 755-757, 2008
1012008
Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation
E Rettinger, AM Willasch, H Kreyenberg, A Borkhardt, W Holter, ...
Blood, The Journal of the American Society of Hematology 118 (20), 5681-5688, 2011
1002011
Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation
S Kuçi, E Rettinger, B Voß, G Weber, M Stais, H Kreyenberg, A Willasch, ...
Haematologica 95 (9), 1579, 2010
912010
NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on …
N Kröger, U Bacher, P Bader, S Böttcher, MJ Borowitz, P Dreger, I Khouri, ...
Biology of Blood and Marrow Transplantation 16 (9), 1187-1211, 2010
892010
Rising incidence of type 1 diabetes in Germany: 12-year trend analysis in children 0–14 years of age
A Neu, S Ehehalt, A Willasch, M Kehrer, R Hub, MB Ranke
Diabetes Care 24 (4), 785-786, 2001
752001
Epidemiological perspectives on type 1 diabetes in childhood and adolescence in Germany: 20 years of the Baden-Württemberg Diabetes Incidence Registry (DIARY)
S Ehehalt, K Dietz, AM Willasch, A Neu, ...
Diabetes care 33 (2), 338-340, 2010
732010
Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study
AM Willasch, B Gruhn, T Coliva, M Kalinova, G Schneider, H Kreyenberg, ...
Leukemia 23 (8), 1472-1479, 2009
682009
Diabetes incidence in children of different nationalities: an epidemiological approach to the pathogenesis of diabetes
A Neu, A Willasch, S Ehehalt, M Kehrer, R Hub, MB Ranke
Diabetologia 44 (3), B21-B26, 2001
572001
WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantation
G Weber, J Karbach, S Kuci, H Kreyenberg, A Willasch, E Koscielniak, ...
Leukemia 23 (9), 1634-1642, 2009
522009
Varying clinical presentations at onset of type 1 diabetes mellitus in children–epidemiological evidence for different subtypes of the disease?
A Neu, S Ehehalt, A Willasch, M Kehrer, R Hub, MB Ranke
Pediatric diabetes 2 (4), 147-153, 2001
512001
Prospective validation of a new method of monitoring minimal residual disease in childhood acute myelogenous leukemia
D Steinbach, P Bader, A Willasch, S Bartholomae, KM Debatin, ...
Clinical Cancer Research 21 (6), 1353-1359, 2015
502015
Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre‐emptive …
P Bader, C Niemeyer, A Willasch, H Kreyenberg, B Strahm, B Kremens, ...
British journal of haematology 128 (5), 649-658, 2005
502005
Real-time PCR quantification of major Wilms’ tumor gene 1 (WT1) isoforms in acute myeloid leukemia, their characteristic expression patterns and possible functional consequences
K Kramarzova, J Stuchly, A Willasch, B Gruhn, J Schwarz, J Cermak, ...
Leukemia 26 (9), 2086-2095, 2012
492012
Rapid immune recovery and low TRM in haploidentical stem cell transplantation in children and adolescence using CD3/CD19-depleted stem cells
P Bader, J Soerensen, A Jarisch, E Ponstingl, T Krenn, J Faber, M Dürken, ...
Best practice & research Clinical haematology 24 (3), 331-337, 2011
492011
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20